Clinical Trial Update: Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of NBI-74788 in Adults With Congenital Adrenal Hyperplasia [Phase 2]

View source ↗

Summary

Phase 2 clinical trial assessing safety, tolerability, pharmacokinetics, and pharmacodynamics of NBI-74788 in adults with congenital adrenal hyperplasia; study …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Congenital Adrenal Hyperplasia

Drugs mentioned

• NBI-74788

Snippet

Sponsor: Neurocrine Biosciences | Conditions: CAH - Congenital Adrenal Hyperplasia | Phase 2 | Status: COMPLETED | Results posted: 2022-05-03